Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma

Christopher D. Mann; Christopher Bastianpillai; Christopher P. Neal; Muhammad M. Masood; Donald J. L. Jones; Friederike Teichert; Rajinder Singh; Elena Karpova; David P. Berry; Margaret M. Manson

doi:10.1371/journal.pone.0051119

Loading metrics

Open Access

Peer-reviewed

Research Article

Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma

Christopher D. Mann,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Christopher Bastianpillai,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Christopher P. Neal,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Muhammad M. Masood,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Donald J. L. Jones,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Friederike Teichert,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Rajinder Singh,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Elena Karpova,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
David P. Berry,

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯
Margaret M. Manson

* E-mail: mmm2@le.ac.uk

Affiliation Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom
⨯

Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma

Christopher D. Mann,
Christopher Bastianpillai,
Christopher P. Neal,
Muhammad M. Masood,
Donald J. L. Jones,
Friederike Teichert,
Rajinder Singh,
Elena Karpova,
David P. Berry,
Margaret M. Manson

Published: December 4, 2012
https://doi.org/10.1371/journal.pone.0051119

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Tumor resection
Is the Subject Area "Tumor resection" applicable to this article?

Thanks for your feedback.
Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Cytoplasmic staining
Is the Subject Area "Cytoplasmic staining" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Pancreatic cancer
Is the Subject Area "Pancreatic cancer" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Lymph nodes
Is the Subject Area "Lymph nodes" applicable to this article?

Thanks for your feedback.
Notch signaling
Is the Subject Area "Notch signaling" applicable to this article?

Thanks for your feedback.